The Influence of Cardiopulmonary Bypass on Platelet Function and Blood Coagulation - Determinants and Clinical Consequences
Has parts
Wahba, A; Black, G; Koksch, M; Rothe, G; Preuner, J; Schmitz, G; Birnbaum, DE. Cardiopulmonary bypass leads to a preferential loss of activated platelets. Europ. J. Cardiothorac. Surg.. 10(9): 768-773, 1996.Wahba, A; Black, G; Koksch, M; Rothe, G; Preuner, J; Schmitz, G; Birnbaum, DE. Aprotinin has no effect on platelet activation and adhesion during cardiopul-monary bypass. Thrombosis and Haemostasis. 75: 844-8, 1996.
Wahba, A; Philipp, A; Bauer, MF; Kaiser, M; Aebert, H; Birnbaum, DE. The blood saving potential of vortex versus roller pump with and without aprotinin. Perfusion. 10: 333-341, 1995.
Wahba, A; Rothe, G; Lodes, H; Barlage, S; Schmitz, G; Birnbaum, DE. Effects of Extracorporeal Circulation and Heparin on the Phenotype of Platelet Surface Antigens following Heart Surgery. Thromb Res. 97: 379-386, 2000.
Wahba, A; Rothe, G; Lodes, H; Barlage, S; Schmitz, G; Birnbaum, DE. Predictors of blood loss after coronary artery bypass grafting. Vasc. Anesth.. 11: 824-827, 1997.
Wahba, A; Sandner, S; Birnbaum, DE. Are in Vitro Platelet Function Tests Useful to Estimate the Blood Loss Following Open Heart Surgery. Thorac. Cardiovasc. Surg. 46: 228-231, 1998.